Andrew Scarsbrook
Leeds Teaching Hospitals NHS Trust
CancerInternal medicineRadiologyPET-CTSurgeryPathologyMagnetic resonance imagingOncologyTomographyFunctional imagingMedical physicsPositron emission tomographyLung cancerHead and neck squamous-cell carcinomaCarcinomaDiseaseMalignancyMEDLINEScintigraphyNuclear medicineIn patientFdg pet ctRadiation therapyComputed tomographyMedicine
206Publications
29H-index
2,565Citations
Publications 134
Newest
#1Ali Al-AmeriH-Index: 1
#2P MalhotraH-Index: 4
Last. Matthew E.J. CallisterH-Index: 18
view all 7 authors...
Background The British Thoracic Society guidelines (2015) on the investigation and management of pulmonary nodules recommend the use of two risk prediction tools to assess the likelihood of malignancy in solid pulmonary nodules (Brock model following initial CT and the model described by Herder et al . following PET-CT). Management strategies are suggested on the basis of these risk assessments. The aim of this study was to assess the performance of this algorithm in patients with solid pulmonar...
Source
#1D. Bird (Leeds Teaching Hospitals NHS Trust)H-Index: 4
#2Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
Last. Robin Prestwich (Leeds Teaching Hospitals NHS Trust)H-Index: 27
view all 14 authors...
Background This study aimed to quantify the variation in oropharyngeal squamous cell carcinoma gross tumour volume (GTV) delineation between CT, MR and FDG PET-CT imaging.
32 CitationsSource
#1Ali Al-AmeriH-Index: 1
#2P MalhotraH-Index: 4
Last. Matthew E.J. CallisterH-Index: 18
view all 8 authors...
Source
#1Sriram VaidyanathanH-Index: 15
#2Chirag PatelH-Index: 14
Last. Fahmid U. ChowdhuryH-Index: 18
view all 4 authors...
Integrated positron emission tomography/computed tomography (PET/CT) with the glucose analogue, 2-[ 18 F]-fluoro-2-deoxy- d -glucose (FDG), is an evolving hybrid imaging technique in the evaluation of an important and diverse group of pathological conditions, which are characterised by infection and aseptic inflammation. With a rapidly expanding body of evidence, it is being increasingly recognised that, in addition to its established role in oncological imaging, FDG PET/CT also has clinical uti...
145 CitationsSource
#1Ali Al-AmeriH-Index: 1
#2P MalhotraH-Index: 4
Last. Matthew E.J. CallisterH-Index: 18
view all 8 authors...
Abstract Objectives Clinical prediction models assess the likelihood of malignancy in pulmonary nodules detected by computed tomography (CT). This study aimed to validate four such models in a UK population of patients with pulmonary nodules. Three models used clinical and CT characteristics to predict risk (Mayo Clinic, Veterans Association, Brock University) with a fourth model (Herder et al. [4] ) additionally incorporating 18Fluorine-Fluorodeoxyglucose (FDG) avidity on positron emission tomo...
84 CitationsSource
#1Sriram VaidyanathanH-Index: 15
Last. Andrew ScarsbrookH-Index: 8
view all 5 authors...
Poster: "ESTI 2015 / P-0060 / Role of F-18 FDG PET-CT in the evaluation of small (<2cm) lung nodules" by: "S. Vaidyanathan, T. Vamadevan, R. S. Naveen, S. Karthik, A. F. Scarsbrook; Leeds/UK"
#1Mark Phillips (Leeds Teaching Hospitals NHS Trust)
#2Kieran Horgan (Leeds Teaching Hospitals NHS Trust)H-Index: 35
Last. Bhavani Rengabashyam (Leeds Teaching Hospitals NHS Trust)H-Index: 1
view all 4 authors...
Source
#1Esme Ferguson (St James's University Hospital)
#2Kavitha Nadesalingam (St James's University Hospital)
Last. Sarah L. Mackie (St James's University Hospital)H-Index: 1
view all 5 authors...
Source
Source
#1Manil Subesinghe (Leeds Teaching Hospitals NHS Trust)H-Index: 12
#2Andrew Scarsbrook (Leeds Teaching Hospitals NHS Trust)H-Index: 29
Last. Robin Prestwich (Leeds Teaching Hospitals NHS Trust)H-Index: 27
view all 12 authors...
Background The use of imaging to implement on-treatment adaptation of radiotherapy is a promising paradigm but current data on imaging changes during radiotherapy is limited. This is a hypothesis-generating pilot study to examine the changes on multi-modality anatomic and functional imaging during (chemo)radiotherapy treatment for head and neck squamous cell carcinoma (HNSCC).
26 CitationsSource